{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T04:27:53Z","timestamp":1768969673968,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005865","name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016923","name":"Hoansha Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.leukres.2013.07.026","type":"journal-article","created":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T14:00:27Z","timestamp":1376402427000},"page":"103-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Suppression of SERPINA1-albumin complex formation by galectin-3 overexpression leads to paracrine growth promotion of chronic myelogenous leukemia cells"],"prefix":"10.1016","volume":"38","author":[{"given":"Ryuko","family":"Nakayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuko","family":"Taniyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mio","family":"Yamamoto-Sugitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayori","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Kiyota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Chinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisao","family":"Nagoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Shimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Horiike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Taniwaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2013.07.026_bib0005","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","article-title":"Molecular biology of bcr-abl1-positive chronic myeloid leukemia","volume":"113","author":"Quint\u00e1s-Cardama","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.07.026_bib0010","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1084\/jem.20062335","article-title":"Oncogenic signaling: new insights and controversies from chronic myeloid leukemia","volume":"204","author":"Van Etten","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2013.07.026_bib0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/156800913804486638","article-title":"Multifaceted mechanisms for cell survival and drug targeting in chronic myelogenous leukemia","volume":"13","author":"Kuroda","year":"2013","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.leukres.2013.07.026_bib0020","doi-asserted-by":"crossref","first-page":"17468","DOI":"10.1073\/pnas.1111138108","article-title":"Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia","volume":"108","author":"Yamamoto-Sugitani","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2013.07.026_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2004.03.012","article-title":"AAT as a diagnostic tool","volume":"352","author":"Lisowska-Myjak","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.leukres.2013.07.026_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.amjmed.2007.07.025","article-title":"Alpha-1 antitrypsin deficiency: pathogenesis, clinical presentation, diagnosis, and treatment","volume":"121","author":"K\u00f6hnlein","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.leukres.2013.07.026_bib0035","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1084\/jem.20042299","article-title":"Serine protease inhibitors serpina1 and serpina3 are down-regulated in bone marrow during hematopoietic progenitor mobilization","volume":"201","author":"Winkler","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2013.07.026_bib0040","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1073\/pnas.0510192103","article-title":"Serpina1 is a potent inhibitor of IL-8-induced hematopoietic stem cell mobilization","volume":"103","author":"van Pel","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2013.07.026_bib0045","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/S0140-6736(05)66781-5","article-title":"Alpha1-antitrypsindeficiency","volume":"365","author":"Stoller","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2013.07.026_bib0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-2867-4-7","article-title":"Alpha1-antitrypsin and its C-terminal fragment attenuate effects of degranulated neutrophil-conditioned medium on lung cancer HCC cells, in vitro","volume":"4","author":"Zelvyte","year":"2004","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.leukres.2013.07.026_bib0055","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/00008469-200304000-00005","article-title":"Multiple effects of alpha1-antitrypsin on breast carcinoma MDA-MB 468 cell growth and invasiveness","volume":"12","author":"Zelvyte","year":"2003","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.leukres.2013.07.026_bib0060","first-page":"745","article-title":"Alpha 1-antitrypsin blocks the release of transforming growth factor-alpha from MCF-7 human breast cancer cells","volume":"82","author":"Yavelow","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.leukres.2013.07.026_bib0065","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood.V83.1.260.260","article-title":"The acute-phase protein alpha 1-antitrypsin inhibits growth and proliferation of human early erythroid progenitor cells (burst-forming units-erythroid) and of human erythroleukemic cells (K562) in vitro by interfering with transferrin iron uptake","volume":"83","author":"Graziadei","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.07.026_bib0070","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1600-0609.2007.00835.x","article-title":"Establishment and characterization of a novel imatinib-sensitive chronic myeloid leukemia cell line MYL, and an imatinib-resistant subline MYL-R showing overexpression of Lyn","volume":"78","author":"Ito","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.leukres.2013.07.026_bib0075","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1182\/blood.V85.4.997.bloodjournal854997","article-title":"Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6\/E7 genes","volume":"85","author":"Roecklein","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.07.026_bib0080","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.1073\/pnas.93.13.6737","article-title":"Expression of galectin-3 modulates T-cell growth apoptosis","volume":"93","author":"Yang","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2013.07.026_bib0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0009-8981(97)00090-9","article-title":"Albumin contamination of a purified human alpha 1-antitrypsin preparation does not affect either structural conformation or the electrophoretic mobility of the inhibitor","volume":"264","author":"Finotti","year":"1997","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.leukres.2013.07.026_bib0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1570-0232(03)00083-7","article-title":"Simple and rapid chromatographic purification of type V collagen from a pepsin digest of porcine intestinal connective tissue, an unmanageable starting material for conventional column chromatography","volume":"790","author":"Sato","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.leukres.2013.07.026_bib0095","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1189\/jlb.1204702","article-title":"Galectin-3 interacts with naive and primed neutrophils, inducing innate immune responses","volume":"78","author":"Nieminen","year":"2005","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.leukres.2013.07.026_bib0100","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/ijc.25946","article-title":"Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of \u03b2-catenin","volume":"129","author":"Kobayashi","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.leukres.2013.07.026_bib0105","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/art.24574","article-title":"Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways","volume":"60","author":"Filer","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.leukres.2013.07.026_bib0110","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/glycob\/cwn015","article-title":"Different affinity of galectins for human serum glycoproteins: galectin-3 binds many protease inhibitors and acute phase proteins","volume":"18","author":"Cederfur","year":"2008","journal-title":"Glycobiology"},{"key":"10.1016\/j.leukres.2013.07.026_bib0115","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.exphem.2009.02.004","article-title":"Serpina1 (alpha1-AT) is synthesized in the osteoblastic stem cell niche","volume":"37","author":"Kuiperij","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1016\/j.leukres.2013.07.026_bib0120","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1084\/jem.178.3.1127","article-title":"Human interferon-inducible protein 10: expression and purification of recombinant protein demonstrate inhibition of early human hematopoietic progenitors","volume":"178","author":"Sarris","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2013.07.026_bib0125","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF01744373","article-title":"Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice","volume":"71","author":"Broxmeyer","year":"1995","journal-title":"Ann Hematol"},{"key":"10.1016\/j.leukres.2013.07.026_bib0130","first-page":"1910","article-title":"Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia","volume":"9","author":"Bruserud","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2013.07.026_bib0135","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/oxfordjournals.annonc.a010607","article-title":"Interleukin 10 inhibits cytokine production of human AML cells","volume":"7","author":"Westermann","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1016\/j.leukres.2013.07.026_bib0140","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0925-5710(97)00070-4","article-title":"Interleukin-10 inhibits the autocrine growth of leukemic blast cells from patients with acute myeloblastic leukemia","volume":"66","author":"Asano","year":"1997","journal-title":"Int J Hematol"},{"key":"10.1016\/j.leukres.2013.07.026_bib0145","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.4049\/jimmunol.182.2.1167","article-title":"Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis","volume":"182","author":"Jiang","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2013.07.026_bib0150","doi-asserted-by":"crossref","first-page":"e4519","DOI":"10.1371\/journal.pone.0004519","article-title":"Lack of galectin-3 drives response to Paracoccidioides brasiliensis toward a Th2-biased immunity","volume":"4","author":"Ruas","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.leukres.2013.07.026_bib0155","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.febslet.2007.02.048","article-title":"Upregulation of the TGFbeta signalling pathway by Bcr-Abl: implications for haemopoietic cell growth and chronic myeloid leukaemia","volume":"581","author":"M\u00f8ller","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.leukres.2013.07.026_bib0160","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature08734","article-title":"TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia","volume":"463","author":"Naka","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2013.07.026_bib0165","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/jb\/mvr016","article-title":"TGF-beta1-induced PI3K\/Akt\/NF-kappaB\/MMP9 signalling pathway is activated in Philadelphia chromosome-positive chronic myeloid leukaemia hemangioblasts","volume":"149","author":"Zhu","year":"2011","journal-title":"J Biochem"},{"key":"10.1016\/j.leukres.2013.07.026_bib0170","doi-asserted-by":"crossref","first-page":"G439","DOI":"10.1152\/ajpgi.00257.2011","article-title":"Galectin-3 modulates phagocytosis-induced stellate cell activation and liver fibrosis in vivo","volume":"302","author":"Jiang","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.leukres.2013.07.026_bib0175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2172-13-31","article-title":"TGF\u03b2 signaling plays a critical role in promoting alternative macrophage activation","volume":"13","author":"Gong","year":"2012","journal-title":"BMC Immunol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613002695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613002695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:59:02Z","timestamp":1758934742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212613002695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0145212613002695"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2013.07.026","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppression of SERPINA1-albumin complex formation by galectin-3 overexpression leads to paracrine growth promotion of chronic myelogenous leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2013.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}